Assistant Professor, Department of Hematology & Oncology Pharmacy Mayo Clinic, Rochester, MN
For patients with advanced breast cancer, prognosis remains especially suboptimal, primarily because of acquired pharmacologic resistance. Fortunately, several new drugs and drug combinations have recently become available.
To sign up for our newsletter or print publications, please enter your contact information below.